• Explore /
  • Poster
  • / Characterization of the microbial resistome in a prospective trial of CBM588 in metastatic renal cell carcinoma (mRCC) offers mechanism for interplay between antibiotic (abx) use and immune checkpoint inhibitor (ICI) activity.

Characterization of the microbial resistome in a prospective trial of CBM588 in metastatic renal cell carcinoma (mRCC) offers mechanism for interplay between antibiotic (abx) use and immune checkpoint inhibitor (ICI) activity.

Abstract Poster

Authors

Nazli Dizman

Nazli Dizman

City of Hope Comprehensive Cancer Center, Duarte, CA

Nazli Dizman , Luis A Meza , Paulo Gustavo Bergerot , Tanya B. Dorff , Yung Lyou , Paul Henry Frankel , Marian Llamas , Joann Hsu , Zeynep Busra Zengin , Jasnoor Malhotra , Ameish Govindarajan , Daniela V. Castro , John D Gillece , Lauren J Reining , Jeffrey M. Trent , Motomichi Takahashi , Kentaro Oka , Seiya Higashi , Sarah K Highlander , Sumanta K. Pal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Clinical Trial Registration Number

NCT03829111

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 4510)

DOI

10.1200/JCO.2022.40.16_suppl.4510

Abstract #

4510

Poster Bd #

2

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Genitourinary Cancers Symposium

Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC).

Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC).

First Author: Regina Barragan-Carrillo

First Author: Garima Gupta

First Author: Pavlina Spiliopoulou

First Author: Jessica Heejin Yoo